Foxit, a leading provider of PDF and eSignature software and services, today announced two significant updates—PDF Editor ...

Americans expect higher unemployment and job-loss risk, New York Fed survey shows Fed expected to cut rates next week amid job market challenges Survey finds consumers' inflation expectations stable ...

Snapchat is launching a new Lens that lets users create and edit images using a text-to-image AI generator, the company told TechCrunch exclusively. The new “Imagine Lens” is available to Snapchat+ ...

New Yorkers are facing additional hurdles to get a Covid-19 vaccine this fall following the federal government’s decision to restrict the shots for most healthy patients. The U.S. Food and Drug ...

Imagine a clock that doesn't have electricity, but its hands and gears spin on their own for all eternity. In a new study, physicists at the University of Colorado Boulder have used liquid crystals, ...

The September Pixel drop includes Material 3 Expressive for Pixel 6 phones and up, along with a big update for the Pixel Buds Pro 2. The September Pixel drop includes Material 3 Expressive for Pixel 6 ...

RPG The next videogame getting its own tabletop RPG is Diablo, an RPG that doesn't have any RP in it RPG Owlcat is 'redoing everything from scratch' in Dark Heresy, its next Warhammer 40,000 CRPG, ...

WASHINGTON – The Republican-controlled House of Representatives voted on party lines on Aug. 3 to create a special panel to reinvestigate the events of the Jan. 6, 2021 insurrection. In 2022, after 18 ...

The Arbalest Launcher is one of the most powerful weapons in Cronos: The New Dawn — and it’s totally optional. This enormous rifle has rare ammunition that’s also overwhelmingly strong. Each shot can ...

HOUSTON — If you’re tired of unwanted sales pitches blowing up your phone, relief may finally be here. A new Texas law, Senate Bill 140, officially took effect on September 1, 2025. It’s designed to ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

A week of fast-moving developments has left some with questions about access to the COVID-19 vaccine. While experts and officials say the new federal guidance surrounding COVID vaccine authorization ...